BCC to Enter Into Joint Venture With Israeli Pharmaceutical Company Panaxia
August 22, 2017 07:00 ET | The Canadian Bioceutical Corporation
Differentiation into high-growth market segment under new “Salus Bio-Pharma” brand JV will launch in Arizona & Massachusetts and, post closing of the acquisitions, in Nevada and Maryland. ...
BCC and MJardin Enter Into Strategic Partnership for U.S. Cannabis Expansion
August 10, 2017 07:00 ET | The Canadian Bioceutical Corporation
TORONTO and DENVER, Aug. 10, 2017 (GLOBE NEWSWIRE) -- The Canadian Bioceutical Corporation (the “Company” or “BCC”) (CSE:BCC) (OTC:CBICF) today announced the signing of a strategic partnership...
BCC Provides Bi-Weekly Update on Status of Management Cease Trade Order
August 09, 2017 17:00 ET | The Canadian Bioceutical Corporation
TORONTO, Aug. 09, 2017 (GLOBE NEWSWIRE) -- The Canadian Bioceutical Corporation (the “Company” or “BCC”) (CSE:BCC) (OTC:CBICF) further to missing the July 31, 2017 deadline for filing its audited...
BCC Announces Application for Management Cease Trade Order
July 25, 2017 07:00 ET | The Canadian Bioceutical Corporation
TORONTO, July 25, 2017 (GLOBE NEWSWIRE) -- The Canadian Bioceutical Corporation (the “Company” or “BCC”) (CSE:BCC) (OTC:CBICF) today announced that it has made an application to the Ontario...
BCC Completes Massachusetts Transaction
June 15, 2017 08:55 ET | The Canadian Bioceutical Corporation
TORONTO, Ontario, June 15, 2017 (GLOBE NEWSWIRE) -- The Canadian Bioceutical Corporation (the “Company” or “BCC”) (CSE:BCC) (OTC:CBICF) today announced that further to its press release of April 4,...
H4LMN
BCC Successfully Relocates Dispensary With First Week Sales Record
May 31, 2017 07:00 ET | The Canadian Bioceutical Corporation
TORONTO, May 31, 2017 (GLOBE NEWSWIRE) -- The Canadian Bioceutical Corporation (the “Company” or “BCC”) (CSE:BCC) (OTCQB:CBICF) today announced that one of the two Health for Life dispensaries...
BCC Secures DTC Eligibility
May 30, 2017 07:00 ET | The Canadian Bioceutical Corporation
TORONTO, May 30, 2017 (GLOBE NEWSWIRE) -- The Canadian Bioceutical Corporation (the “Company” or “BCC”) (CSE:BCC) (OTCQB:CBICF) today announced that the company has secured DTC Eligibility by The...
BCC Commences Trading on OTCQB
May 22, 2017 07:00 ET | The Canadian Bioceutical Corporation
TORONTO, May 22, 2017 (GLOBE NEWSWIRE) -- The Canadian Bioceutical Corporation (the “Company” or “BCC”) (CSE:BCC) (OTCQB:CBICF) announced that BCC common shares will commence trading in the...
BCC to Expand U.S. Footprint With Arizona and Maryland Acquisitions
May 17, 2017 08:00 ET | The Canadian Bioceutical Corporation
Accretive Arizona Target  Entry into early-stage, populous Maryland market TORONTO, May 17, 2017 (GLOBE NEWSWIRE) -- (CSE:BCC) (OTC:CBICF) The Canadian Bioceutical Corporation (the “Company”...
BCC expands into second adult use market
May 04, 2017 07:00 ET | The Canadian Bioceutical Corporation
TORONTO, May 04, 2017 (GLOBE NEWSWIRE) -- The Canadian Bioceutical Corporation (the “Company” or “BCC”) (CSE:BCC)(OTC:CBICF) today announced that the Company, through its wholly owned U.S....